Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of PEG ratio.
Trinity Biotech plc TRIB has a PEG ratio of 0.52. Trinity Biotech's trailing-twelve-month profit margin is 17.20%.
Meridian Bioscience, Inc. VIVO has a PEG ratio of 1.84. Meridian Bioscience's trailing-twelve-month EPS is $0.83.
SurModics, Inc. SRDX has a PEG ratio of 1.89. SurModics' trailing-twelve-month ROE is 12.90%.
Neogen Corp. NEOG has a PEG ratio of 3.63. Neogen's trailing-twelve-month revenue is $265.30 million.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in